Together, these data demonstrate that in B-ALL the expression of MTOR is regulated by the CK2-IKAROS signaling axis, and that alteration in activity of CK2 and/or IKAROS results in changes in MTOR expression. The gene discussed is IKZF1; the disease is precursor B-cell acute lymphoblastic leukemia.